Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China.

Wang M, Yuan J, Li T, Liu Y, Wu J, Di B, Chen X, Xu X, Lu E, Li K, Liu Y, Wu Y, Chen X, He P, Wang Y, Liu J.

PLoS One. 2011 Feb 9;6(2):e16809. doi: 10.1371/journal.pone.0016809.

2.

[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].

You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4. Chinese.

PMID:
22338222
3.

Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.

Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.

HIV Med. 2012 Jul;13(6):352-7. doi: 10.1111/j.1468-1293.2011.00987.x. Epub 2012 Feb 2.

4.

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.

Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.

5.

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.

Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I.

Influenza Other Respir Viruses. 2013 May;7(3):431-8. doi: 10.1111/j.1750-2659.2012.00415.x. Epub 2012 Aug 23.

6.

Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.

Salles MJ, Sens YA, Malafronte P, Souza JF, Vilas Boas LS, Machado CM.

Transpl Infect Dis. 2012 Dec;14(6):564-74. doi: 10.1111/j.1399-3062.2012.00769.x. Epub 2012 Aug 13.

PMID:
22882692
7.

Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.

Huijskens EG, Reimerink J, Mulder PG, van Beek J, Meijer A, de Bruin E, Friesema I, de Jong MD, Rimmelzwaan GF, Peeters MF, Rossen JW, Koopmans M.

PLoS One. 2013;8(1):e54890. doi: 10.1371/journal.pone.0054890. Epub 2013 Jan 24.

8.

Immune response to influenza vaccination in community-dwelling Chinese elderly persons.

Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.

Vaccine. 2006 Jun 19;24(25):5371-80. Epub 2006 May 3.

PMID:
16713661
9.

Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan.

Chan YJ, Lee CL, Hwang SJ, Fung CP, Wang FD, Yen DH, Tsai CH, Chen YM, Lee SD.

J Chin Med Assoc. 2010 Feb;73(2):62-6. doi: 10.1016/S1726-4901(10)70003-4.

10.

[Analysis of influenza type A(H1N1) antibody levels in different population in Gansu province].

Yu DS, Li HY, Gao XM.

Zhongguo Yi Miao He Mian Yi. 2010 Jun;16(3):219-21, 260. Chinese.

PMID:
20726261
11.

Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients.

Moon SJ, Lee SH, Byun YH, Yun GY, Kim SK, Seong BL, Kim AR, Sun Park E, Kim HJ, Lee JE, Ha SK, Lee JM, Park HC.

BMC Nephrol. 2012 Dec 3;13:165. doi: 10.1186/1471-2369-13-165.

12.

[Herd immunity against new influenza A (H1N1) in pre-vaccinated residents aged over 5 years in Beijing].

Lu L, Liu DL, Zhang TG, Chen M, Zhang ZJ, Wang XL, Yang Z, Pang XH, Deng Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Jun;33(6):403-5. Chinese.

PMID:
20979808
13.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.

N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.

14.

Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.

Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, Zhao S, Wang Y, Zhou R, Chen R.

Jpn J Infect Dis. 2011;64(3):190-4.

15.

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.

Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.

PMID:
22475864
16.

High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.

Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1121-7. doi: 10.1002/acr.21948.

17.

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.

Lagler H, Wenisch JM, Tobudic S, Gualdoni GA, Rödler S, Rasoul-Rockenschaub S, Jaksch P, Redlberger-Fritz M, Popow-Kraupp T, Burgmann H.

Vaccine. 2011 Sep 16;29(40):6888-93. doi: 10.1016/j.vaccine.2011.07.050. Epub 2011 Jul 29.

PMID:
21803100
18.

"Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?".

Allwinn R, Bickel M, Lassmann C, Wicker S, Friedrichs I.

Med Microbiol Immunol. 2013 Apr;202(2):125-30. doi: 10.1007/s00430-012-0259-9. Epub 2012 Sep 19.

PMID:
22986732
19.

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, Loucaides E, Howe K, Szydlo R, Kanfer E, Macdonald D, Kelleher P, Cooper N, Khoder A, Gabriel IH, Milojkovic D, Pavlu J, Goldman JM, Apperley JF, Rezvani K.

Haematologica. 2011 Feb;96(2):307-14. doi: 10.3324/haematol.2010.032664. Epub 2010 Oct 22.

20.

[Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].

Shen HH, Hou J, Zhao M, Xu J, Bai BK, Zhao J, Hu Y, Mao PY, Li BA, Mao YL.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Aug;26(4):270-2. Chinese.

PMID:
23189841

Supplemental Content

Support Center